Recent advances in pharmacological treatment of heart failure-Reference-Cited by-同舟云学术

Recent advances in pharmacological treatment of heart failure

Published:2021-06-15 Issue:11 Volume:51 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Iacoviello Massimo¹^ORCID,Palazzuoli Alberto²^ORCID,Gronda Edoardo³^ORCID

Affiliation:

1. Cardiology Unit Department of Medical and Surgical Science University of Foggia Foggia Italy

2. Cardiovascular Diseases Unit Department of Internal Medicine S. Maria alle Scotte Hospital University of Siena Siena Italy

3. Dialisi e Trapianto Renale dell’adulto Dipartimento Di Medicina e Specialità Mediche Fondazione IRCCS Ca’ Granda ‐ Ospedale Maggiore Policlinico di Milano UOC di Nefrologia Milan Italy

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13624

Reference96 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction

3. Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction

4. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

5. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Treatment of Heart Failure: Recent Advances;Current Cardiology Reviews;2024-03

2. Sacubitril/valsartan inhibits the proliferation of vascular smooth muscle cells through notch signaling and ERK1/2 pathway;BMC Cardiovascular Disorders;2024-02-14

3. Mast Cells in Cardiac Remodeling: Focus on the Right Ventricle;Journal of Cardiovascular Development and Disease;2024-02-04

4. Advances in 3D bioprinting for regenerative medicine applications;Regenerative Biomaterials;2024-01-01

5. The Therapeutic Potential of Targeting Ferroptosis in the Treatment of Mitochondrial Cardiomyopathies and Heart Failure;Journal of Cardiovascular Pharmacology;2024-01